Target intelligence / Profile preview

Accessible skin proteins

Molecular classification
Structural protein, Enzyme, Other
01

Overview

Accessible skin proteins refers to the collective group of proteins located in the outermost layers of the skin, primarily the stratum corneum and viable epidermis, which are readily available for interaction with topically applied substances (AOP Wiki, 2023). This group includes structural proteins such as keratins (e.g., Keratin 1, 5, 10, and 14), filaggrin, and loricrin, as well as extracellular matrix proteins like collagen and elastin in the deeper layers (UniProt, 2024). In the context of pharmacology and toxicology, these proteins are critical as the primary site for the Molecular Initiating Event (MIE) of skin sensitization, where electrophilic chemicals (haptens) covalently bind to nucleophilic residues like cysteine or lysine to form complete antigens (OECD, 2014). Additionally, these proteins are targeted by keratolytic agents such as salicylic acid to treat hyperkeratotic conditions and are utilized in drug delivery strategies to create reservoirs that prolong the local residence time of topical therapeutics (StatPearls, 2023; PubMed, 2018). Understanding the interaction between drugs and these accessible proteins is essential for predicting skin sensitization potential and optimizing the efficacy of dermatological treatments.

Other names
Epidermal proteinsStratum corneum proteinsSkin-binding proteinsHapten-binding proteinsDermal proteins
02

Mechanism of action

Covalent binding (haptenation), Keratolysis, Protein denaturation, and Drug reservoir formation

03

Biological functions

Barrier functionImmune responseCellular structureHomeostasis
04

Disease associations

Allergic contact dermatitisAtopic dermatitisPsoriasisIchthyosis
05

Safety considerations

Skin sensitizationContact dermatitisIrritationImpaired barrier function
06

Interacting drugs

Salicylic acid

7 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Keratin 1 expressionKeratin 10 expressionFilaggrin levelsPeptide depletion (DPRA)

Beyond the preview

Go deeper on Accessible skin proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accessible skin proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call